Angiotensin receptor blocker
Pro Research Analysisby 
Searched over 200M research papers
Angiotensin Receptor Blockers (ARBs): Mechanism and Clinical Uses
Angiotensin receptor blockers (ARBs) are medications commonly prescribed for high blood pressure, heart failure, and kidney disease. They work by blocking the effects of angiotensin II, a hormone that causes blood vessels to constrict, increases salt and water retention, and can lead to harmful changes in the heart and kidneys. By preventing angiotensin II from binding to its receptor, ARBs help relax blood vessels, lower blood pressure, and reduce strain on the heart and kidneys .
Efficacy in Hypertension and Cardiovascular Disease
ARBs are recommended as first-line or add-on therapy for hypertension in national guidelines. They are effective in lowering blood pressure and are often combined with other medications like thiazide diuretics or calcium channel blockers for better control. Beyond blood pressure reduction, ARBs provide benefits in heart failure and diabetic kidney disease, especially for patients who cannot tolerate angiotensin-converting enzyme inhibitors (ACEIs) due to side effects like cough or angioedema Hm2014Schiffrin2002.
Heart Failure and Renal Protection
ARBs have shown significant benefits in heart failure, reducing hospitalizations and improving symptoms and quality of life. For example, valsartan, an ARB, reduced the combined risk of death and hospitalization in patients with heart failure when added to standard therapy, although caution is needed when combining ARBs with both ACE inhibitors and beta-blockers due to potential safety concerns . ARBs also help protect the kidneys, particularly in patients with diabetes, by reducing protein loss in urine and slowing kidney damage Hm2014Schiffrin2002.
Safety and Tolerability
ARBs are generally well tolerated, with fewer side effects compared to ACE inhibitors. This makes them a preferred option for many patients, improving adherence to treatment . However, combining ARBs with other renin-angiotensin system blockers is no longer recommended due to a lack of added benefit and increased risk of kidney problems .
Additional Benefits Beyond Blood Pressure Control
Research shows that ARBs have protective effects beyond lowering blood pressure. They reduce inflammation, protect blood vessel and heart function, and may help in conditions like stroke, coronary heart disease, and diabetic nephropathy Schiffrin2002Saavedra2021. ARBs also show potential in reducing the risk of epilepsy compared to other blood pressure medications, especially in patients without a history of stroke or cardiovascular disease .
ARBs and COVID-19
ARBs may offer protective effects for the lungs in viral infections, including COVID-19, by reducing inflammation and enhancing the protective role of ACE2. Continuing ARB therapy is recommended for patients with hypertension, diabetes, or kidney disease during the COVID-19 pandemic .
Angiogenesis and Cancer Concerns
There is conflicting evidence about the effects of ARBs on angiogenesis (the formation of new blood vessels). Some studies suggest ARBs may reduce abnormal blood vessel growth in diseases like cancer and retinopathy, while others show increased vascular density in recovery from heart attack or stroke. The overall impact on cancer risk remains unclear and requires further research .
Limitations in Reducing Mortality
While ARBs effectively lower blood pressure and reduce the risk of stroke and heart failure, studies have not shown a reduction in the risk of heart attack, cardiovascular death, or overall mortality compared to placebo or other treatments. This is sometimes referred to as the "ARB-MI paradox" .
Use in Dermatology and Other Areas
ARBs are sometimes used in dermatology, mainly for patients who cannot tolerate ACE inhibitors, but evidence for their effectiveness in skin conditions is limited and mostly anecdotal .
Conclusion
Angiotensin receptor blockers are important medications for managing high blood pressure, heart failure, and kidney disease, especially in patients who cannot tolerate ACE inhibitors. They are well tolerated, effective in reducing blood pressure, and offer additional protective benefits for the heart, kidneys, and possibly the brain. However, their impact on reducing overall mortality is limited, and their role in cancer risk and other conditions continues to be studied.
Sources and full results
Most relevant research papers on this topic